Showing results (321-330 of 330) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 330 results.
Bioorganic & Medicinal Chemistry|September 15, 2009
Novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potent and orally active STAT6 inhibitorsShinya Nagashima, Takeshi Hondo, Hiroshi Nagata, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2025
Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter studyAkihiro Tsukaguchi, Kinnosuke Matsumoto, Akihiro Tamiya, et al.
Scandinavian Journal of Gastroenterology|November 6, 2015
Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classificationKazuhiko Nakamura, Mikako Osada, Ayako Goto, et al.
Respiratory Medicine|April 23, 2026
Impact of pre-existing interstitial lung abnormalities on pneumonitis risk and survival in chemo-naive patients with non-small-cell lung cancer receiving pembrolizumab plus chemotherapyHirotomo Machiyama, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
JTO Clinical and Research Reports|March 19, 2026
Clinical Outcomes of First-Line Pembrolizumab Monotherapy in Advanced NSCLC With PD-L1 Tumor Proportion Score of 1% to 49%: A Retrospective Multicenter StudyAkito Miyazaki, Kinnosuke Matsumoto, Motohiro Tamiya, et al.
Bioorganic & Medicinal Chemistry|January 27, 2005
Studies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivativesNaoyuki Masuda, Osamu Yamamoto, Masahiro Fujii, et al.
Bioorganic & Medicinal Chemistry|November 3, 2004
Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamidesNaoyuki Masuda, Osamu Yamamoto, Masahiro Fujii, et al.
BMC Genomics|September 4, 2016
A full-body transcriptome and proteome resource for the European common carpI C R M Kolder, S J van der Plas-Duivesteijn, G Tan, et al.
JTO Clinical and Research Reports|October 27, 2025
A Multicenter, Retrospective, Real-World Study of Atezolizumab Plus Chemotherapy and Pembrolizumab Plus Chemotherapy for Older Patients With NSCLCKensuke Kanaoka, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2026
Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancerKinnosuke Matsumoto, Yuji Yamamoto, Takayuki Shiroyama, et al.
Pageof 33